[1]罗孜贤,田浩.血清溶质载体家族7成员11、沉默信息调节蛋白1、酰基辅酶A合成酶长链家族成员4与急性脑梗死缺血再灌注损伤及预后的相关性[J].陕西医学杂志,2026,(7):935-939.[doi:DOI:10.3969/j.issn.1000-7377.2026.07.011]
点击复制

血清溶质载体家族7成员11、沉默信息调节蛋白1、酰基辅酶A合成酶长链家族成员4与急性脑梗死缺血再灌注损伤及预后的相关性

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2026年7期
页码:
935-939
栏目:
临床研究
出版日期:
2026-07-05

文章信息/Info

作者:
罗孜贤1田浩2
(1.武汉科技大学附属紫荆医院 武汉紫荆医院神经内科,湖北 武汉 430062;2.湖北省第三人民医院神经内科,湖北 武汉 430033)
关键词:
溶质载体家族7成员11沉默信息调节蛋白1酰基辅酶A合成酶长链家族成员4急性脑梗死缺血再灌注损伤预后
分类号:
R 743.3
DOI:
DOI:10.3969/j.issn.1000-7377.2026.07.011
文献标志码:
A
摘要:
目的:探讨血清溶质载体家族7成员11(SLC7A11)、沉默信息调节蛋白1(SIRT1)、酰基辅酶A合成酶长链家族成员4(ACSL4)与急性脑梗死缺血再灌注损伤及预后的关系。方法:选取急性脑梗死患者218例,治疗后发生再灌注损伤患者42例(缺血再灌注损伤组),未发生再灌注损伤患者176(非缺血再灌注损伤组)。其中缺血再灌注损伤组中预后不良12例,预后良好30例。比较缺血再灌注损伤组和非缺血再灌注损伤组血清SLC7A11、SIRT1、ACSL4差异,以及缺血再灌注损伤组不同预后患者间血清SLC7A11、SIRT1、ACSL4差异。结果:缺血再灌注损伤组患者血清SLC7A11和SIRT1分别为(14.43±3.43)ng/ml和(4.65±1.02)g/L,明显低于非缺血再灌注损伤组(均P<0.05),而ACSL4为(47.28±8.21)ng/ml,明显高于非缺血再灌注损伤组(P<0.05)。缺血再灌注损伤组预后不良患者血清SLC7A11和SIRT1分别为(13.15±2.24)ng/ml和(4.14±0.98)g/L,明显低于预后良好患者(均P<0.05),而ACSL4为(50.32±5.04)ng/ml,明显高于预后良好患者(P<0.05)。血清SLC7A11、SIRT1、ACSL4预测缺血再灌注损伤的ROC曲线下面积分别为0.666(95%CI:0.584~0.748)、0.840(95%CI:0.778~0.901)和0.758(95%CI:0.677~0.839)(均P<0.05)。血清SLC7A11、SIRT1、ACSL4预测缺血再灌注损伤患者预后不良的ROC曲线下面积分别为0.833(95%CI:0.695~0.971)、0.781(95%CI:0.600~0.961)和0.897(95%CI:0.802~0.993)(均P<0.05)。结论:急性脑梗死缺血再灌注损伤患者血清SLC7A11和SIRT1水平降低,而ACSL4水平升高,三者在预测急性脑梗死缺血再灌注损伤及缺血再灌注损伤后预后方面均有一定应用价值。

参考文献/References:

[1]HU J,TIAN M.The cGAS-STING pathway in ischemia-reperfusion injury in acute cerebral infarction:A new therapeutic opportunities?[J].Front Neurol,2024,15(8):e1471287.
[2]LIAO Y,ZHANG Q,SHI Q,et al.Neuroserpin alleviates cerebral ischemia-reperfusion injury by suppressing ischemia-induced endoplasmic reticulum stress[J].Neural Regen Res,2026,21(1):333-345.
[3]MEN D,HUANG Z,LIN H,et al.Edaravone dexborneol attenuates neuroinflammation in acute cerebral ischemia-reperfusion injury through the CXCL13/CXCR5/NF-κB pathway[J].Immunopharmacol Immunotoxicol,2025,47(6):897-908.
[4]WANG K,ZHOU W,WEN L,et al.The protective effects of axitinib on blood-brain barrier dysfunction and ischemia-reperfusion injury in acute ischemic stroke[J].Exp Neurol,2024,379(8):e114870.
[5]ZHOU Y F,YANG S B,ZHANG F,et al.Microvascular endothelial metabolic dysfunction drives cerebral edema through bioenergetic failure after ischemia-reperfusion[J].Theranostics,2026,16(7):3577-3598.
[6]SUN J,ZHAO K,ZHANG W,et al.Ecdysterone improves oxidative damage induced by acute ischemic stroke via inhibiting ferroptosis in neurons through ACSL4[J].J Ethnopharmacol,2024,331(7):e118204.
[7]ZHU X,ZHAO Z,ZHANG Y,et al.P38γ modulates ferroptosis in brain injury caused by ethanol and cerebral ischemia/reperfusion by regulating the p53/SLC7A11 signaling pathway[J].Cell Signal,2025,131(5):e111728.
[8]TEERTAM S K,JHA S,PRAKASH BABU P.Up-regulation of Sirt1/miR-149-5p signaling may play a role in resveratrol induced protection against ischemia via p53 in rat brain[J].J Clin Neurosci,2020,72(2):402-411.
[9]中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):17.
[10]HUA Y,ZHAI Y,WANG G,et al.Tong-qiao-huo-xue decoction activates PI3K/Akt/mTOR pathway to reduce BMECs autophagy after cerebral ischemia/reperfusion injury[J].J Ethnopharmacol,2022,298(2):e115585.
[11]SHANG W,ZHANG Y,XUE L,et al.Evaluation of collateral circulation and short-term prognosis of patients with acute cerebral infarction by perfusion-weighted MRI[J].Ann Palliat Med,2022,11(4):1351-1359.
[12]LIU C D,PENG Q,WANG S Y,et al.Circ_0008146 exacerbates ferroptosis via regulating the miR-342-5p/ACSL4 axis after cerebral ischemic/reperfusion[J].J Inflamm Res,2024,17(2):4957-4973.
[13]李雪,薛素芳,王淳秀,等.急性心脑梗死临床特征及治疗转归的研究[J].医学研究杂志,2024,53(1):131-135.
[14]贾俊兴,倪彩丽,王永霞.急性脑梗死后缺血再灌注的脑保护研究[J].脑与神经疾病杂志,2024,32(12):785-788.
[15]PENG Q,DENG Y,XU Z,et al.Fat mass and obesity-associated protein alleviates cerebral ischemia/reperfusion injury by inhibiting ferroptosis via miR-320-3p/SLC7A11 axis[J].Biochem Pharmacol,2024,230(2):e116603.
[16]WU P,CHENG L H,LIU Y L,et al.Elemene mitigates oxidative stress and neuronal apoptosis induced by cerebral ischemia-reperfusion injury through the regulation of glutathione metabolism[J].J Ethnopharmacol,2025,340(8):e119166.
[17]LIU H,ZHANG T A,ZHANG W Y,et al.Rhein attenuates cerebral ischemia-reperfusion injury via inhibition of ferroptosis through NRF2/SLC7A11/GPX4 pathway[J].Exp Neurol,2023,369(3):e114541.
[18]WANG K J,ZHANG W Q,LIU J J,et al.Piceatannol protects against cerebral ischemia/reperfusion induced apoptosis and oxidative stress via the Sirt1/FoxO1 signaling pathway[J].Mol Med Rep,2020,22(6):5399-5411.
[19]MEI Z,DU L,LIU X,et al.Diosmetin alleviated cerebral ischemia/reperfusion injury in vivo and in vitro by inhibiting oxidative stress via the SIRT1/Nrf2 signaling pathway[J].Food Funct,2022,13(1):198-212.
[20]MAO R,LIU H.Depletion of mmu_circ_0001751 (circular RNA Carm1) protects against acute cerebral infarction injuries by binding with microRNA-3098-3p to regulate acyl-CoA synthetase long-chain family member 4[J].Bioengineered,2022,13(2):4063-4075.
[21]QIAN W,CHEN X,GU L,et al.Herbacetin alleviates ferroptosis via Hif-1α/SLC7A11/GPX4 axis in traumatic brain injury[J].Free Radic Biol Med,2025,238(7):179-193.
[22]马睿,魏斌,管晓东,等.酰基辅酶A合成酶长链家族成员4对卵巢癌细胞生物学行为影响的实验研究[J].临床肿瘤学杂志,2025,30(12):1145-1151.
[23]DAI Y,CHEN Y,MO D,et al.Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease[J].Commun Biol,2023,6(1):907-912.
[24]熊英琼,江铃铃,彭毓棻,等.基于磷脂酰肌醇3激酶/蛋白激酶B信号通路探究麦冬皂苷D对脑缺血再灌注损伤的神经保护作用[J].陕西医学杂志,2026,55(1):35-42.

相似文献/References:

[1]李义,杨彦君,殷天坪,等.NCOA4调控SLC7A11/GPX4通路对膝骨关节炎大鼠软骨细胞铁死亡的影响实验研究[J].陕西医学杂志,2025,54(6):729.[doi:DOI:10.3969/j.issn.1000-7377.2025.06.002]
 LI Yi,YANG Yanjun,YIN Tianping,et al.Effect of NCOA4 on ferroptosis of chondrocytes in rats with knee osteoarthritis by regulating SLC7A11/GPX4 pathway[J].,2025,54(7):729.[doi:DOI:10.3969/j.issn.1000-7377.2025.06.002]

备注/Memo

备注/Memo:
湖北省自然科学基金资助项目(2022CFB870,2022CFB434)
更新日期/Last Update: 2026-07-10